Purpose: Cranial SRS uses non-coplanar fixed IMRT beams or arc to reach clinically acceptable
radiosurgery plans. Elements cranial SRS software uses a 4Pi optimization algorithm
and clinical Protocols for couch angle selection, start /stop gantry angle and trajectory
optimization. The objective of this work was to evaluate the initial experience using
Elements cranial SRS software v1.5. Methods: The first 39 SRS treatment plans were selected. The pathologies associated were acoustic
neurinomas (#7, 13Gy - 1 fraction, #2, 25Gy - 5 fractions and #5, 18Gy - 3 fraction),
pituitary macroadenoma (#1, 25Gy - 1 fraction and #4, 27Gy - 5 fractions), meningioma
(#1, 13Gy - 1 fractions; #1, 16Gy - 1 fraction; #1, 18Gy - 3 fraction and #2, 30Gy
- 5 fractions), cavernoma (#2, 16Gy - 1 fraction), hamartoma (#2, 22Gy - 1 fraction),
metastasis (#1, 25Gy - 1 fraction, #2, 30Gy - 3 fractions and #2, 27Gy - 3 fractions),
craniopharyngioma (#1, 27Gy - 5 fractions and #1, 21Gy - 3 fractions), capillary hemangioma
(#1, 21Gy - 3 fractions) and glioblastoma (#3, 36/25Gy - 5 fractions). Clinical protocols
were created for each treatment. Plans were evaluated by monitor units (MU), conformity
index (CI) and gradient index (GI). Patient specific QA was done by EBT3 film (global
gamma, 2%- 2mm analyzed by RIT software v6.7), Delta4 (local and global gamma, 2%-2mm,
ScandiDos), ion chamber measurement (PinPoint chamber within and in-house head phantom)
and independent MU calculation (RadCalc v6.3). Results: All plans fulfil the clinical plan quality and OARs dose constraints. The average
PTV volume was 6.0cc [0.5, 33.2], MU needed to deliver 10 Gy was 2756MU [1682, 6092],
CI 1.2 [1.1, 1.7] and GI 3.0 [2.1, 5.2]. EBT3 film global gamma was better than 97.6%
and for 88% of the plans better than 99.4%. Delta4 local gamma was better than 92.7%
and global gamma better than 96.2%. The average ion chamber dose variation was 1.2%
[-3.5, 5.4] and independent MU calculation variation was 3.1% [0.1, 8]. Conclusion: The implementation of Elements Cranial SRS present good results for CI, GI and patient
specific QA. According to the previous results, it is concluded that Elements Cranial
SRS is a tool that comply the requirements for its continuous use in the clinic.
Bibliographical Record
Ana Maria Cardona, Carlos Daniel Venencia, Albin Ariel Garcia. INITIAL EXPERIENCE
USING BRAINLAB ELEMENTS CRANIAL SRS. Brazilian Journal of Oncology 2019; 15.
DOI: 10.1055/s-0044-1798206